Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Medicines (Basel, Switzerland)|August 6, 2021
Effectiveness of Yoga Lifestyle on Lipid Metabolism in a Vulnerable Population-A Community Based Multicenter Randomized Controlled TrialRaghuram Nagarathna, Saurabh Kumar, Akshay Anand, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|August 3, 2016
American Clinical Neurophysiology Society: EEG Guidelines IntroductionTammy N Tsuchida, Jayant N Acharya, Jonathan J Halford, et al.
The Neurodiagnostic Journal|April 25, 2017
American Clinical Neurophysiology Society: EEG Guidelines IntroductionTammy N Tsuchida, Jayant N Acharya, Jonathan J Halford, et al.
Epilepsy Currents|September 18, 2020
The Impact of COVID-19 on Epilepsy Care: A Survey of the American Epilepsy Society MembershipDara V F Albert, Rohit R Das, Jayant N Acharya, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|June 13, 2001
Etiology and management of obscure gastrointestinal bleed--an appraisal from eastern IndiaG Ray, P K Banerjee, U C Ghoshal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1980
Radiorespirometric testing of antibiotic sensitivity in urinary tract infections: concise communicationK T Singh, R D Ganatra, D H Shah, et al.
Journal of Food Protection|April 12, 2013
Screening of condensed tannins from Canadian prairie forages for anti-Escherichia coli O157:H7 with an emphasis on purple prairie clover (Dalea purpurea Vent)Y Wang, L Jin, K H Ominski, et al.
Genome|January 4, 2017
Transcript analysis in two alfalfa salt tolerance selected breeding populations relative to a non-tolerant populationM Y Gruber, J Xia, M Yu, et al.
Genome Research|February 15, 2023
Atlas-scale single-cell chromatin accessibility using nanowell-based combinatorial indexingBrendan L O'Connell, Ruth V Nichols, Dmitry Pokholok, et al.
The British Journal of Dermatology|June 11, 2017
Infections from seven clinical trials of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriasisK A Papp, H Bachelez, A Blauvelt, et al.
Pageof 14